Shohei Nagasaka
Kitakyushu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Molecular and clinical prognostic factors in isocitrate dehydrogenase-mutant astrocytomas: Insights into biomarker-driven stratification.
Journal: Journal of neuropathology and experimental neurology
Published: February 14, 2026
Talaporfin Sodium as a Clinically Translatable Radiosensitizer in Radiodynamic Therapy.
Journal: Biomolecules
Published: November 07, 2025
Caspase-4 deficiency impairs nuclear actin-mediated DNA double-strand break repair and increases radiosensitivity in cancer cells.
Journal: Biochemical and biophysical research communications
Published: September 29, 2025
Single-center retrospective study of factors associated with early discontinuation of tumor-treating fields therapy in glioblastoma.
Journal: Oncology letters
Published: August 22, 2025
Return to work and factors influencing recovery after endoscopic transsphenoidal surgery for hypothalamic and pituitary tumors.
Journal: Scientific reports
Published: July 02, 2025
Genetic Basis and Clinical Management of Schwannomatosis.
Journal: Journal of Korean Neurosurgical Society
Published: January 03, 2025
Imaging-tracked progression of primary leptomeningeal gliomatosis: A case report.
Journal: Surgical neurology international
Published: September 07, 2024
Meningioma‑associated parkinsonism related to basal ganglia and cerebellar motor circuits: A case report and literature review.
Journal: Experimental and therapeutic medicine
Published: July 08, 2024
Caspase-4 has a role in cell division in epithelial cells through actin depolymerization.
Journal: Biochemical and biophysical research communications
Published: December 01, 2023
Caspase-4 promotes metastasis and interferon-γ-induced pyroptosis in lung adenocarcinoma.
Journal: Communications biology
Published: September 12, 2023
Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma.
Journal: Neuro-oncology advances
Published: August 02, 2023
Last Updated: 09/26/2026